← Back to Discover
Artia Global Partners LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $541,855,576
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $68,821,727
- INSMED INC · COM PAR $.01 · 457669307 · shares: $62,804,724
- TREVI THERAPEUTICS INC · COM · 89532M101 · shares: $41,232,390
- BRIGHTSPRING HEALTH SVCS INC · COM · 10950A106 · shares: $36,077,548
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares: $34,719,839
- ARGENX SE · SPONSORED ADR · 04016X101 · shares: $27,590,952
- ALKERMES PLC · SHS · G01767105 · shares: $23,523,469
- TRAVERE THERAPEUTICS INC · COM · 89422G107 · shares: $19,260,465
- ASTRAZENECA PLC · ORD · G0593M107 · shares: $18,654,057
- NEWAMSTERDAM PHARMA COMPANY · ORDINARY SHARES · N62509109 · shares: $17,078,391
Reported holdings
48 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 516,447 shares | $68,821,727 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 589,052 shares | $62,804,724 |
| TREVI THERAPEUTICS INC | COM | 89532M101 | — | 2,210,852 shares | $41,232,390 |
| BRIGHTSPRING HEALTH SVCS INC | COM | 10950A106 | — | 517,315 shares | $36,077,548 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 185,390 shares | $34,719,839 |
| ARGENX SE | SPONSORED ADR | 04016X101 | — | 29,739 shares | $27,590,952 |
| ALKERMES PLC | SHS | G01767105 | — | 448,964 shares | $23,523,469 |
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | — | 339,033 shares | $19,260,465 |
| ASTRAZENECA PLC | ORD | G0593M107 | — | 98,376 shares | $18,654,057 |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | — | 503,936 shares | $17,078,391 |
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 162,990 shares | $15,888,265 |
| SPDR SERIES TRUST | ST STR SP BIOT | 78464A870 | PUT | 100,000 shares | $15,825,000 |
| QUEST DIAGNOSTICS INC | COM | 74834L100 | — | 65,122 shares | $13,802,608 |
| IONIS PHARMACEUTICALS INC | COM | 462222100 | — | 144,376 shares | $11,447,573 |
| EYEPOINT INC | COM NEW | 30233G209 | — | 767,098 shares | $10,969,501 |
| ALUMIS INC | COM | 022307102 | — | 278,546 shares | $7,838,284 |
| VIKING THERAPEUTICS INC | COM | 92686J106 | — | 180,731 shares | $7,050,316 |
| CELCUITY INC | COM | 15102K100 | — | 59,316 shares | $6,205,640 |
| CYTOKINETICS INC | COM NEW | 23282W605 | — | 70,700 shares | $6,022,933 |
| MERCK & CO INC | COM | 58933Y105 | — | 46,700 shares | $6,000,950 |
| RAPPORT THERAPEUTICS INC | COM | 75383L102 | — | 138,508 shares | $5,771,628 |
| JOHNSON & JOHNSON | COM | 478160104 | — | 22,600 shares | $5,739,722 |
| GUARDANT HEALTH INC | COM | 40131M109 | — | 38,100 shares | $5,716,143 |
| ABSCI CORPORATION | COM | 00091E109 | — | 464,444 shares | $5,382,906 |
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | — | 96,285 shares | $5,295,675 |
| SIONNA THERAPEUTICS INC | COM | 829401108 | — | 119,741 shares | $5,267,407 |
| ASCENDIS PHARMA A/S | ORD SHS | K08588103 | — | 17,740 shares | $4,731,613 |
| ROIVANT SCIENCES LTD | SHS | G76279101 | — | 129,800 shares | $4,593,622 |
| PALISADE BIO INC | COM | 696389402 | — | 1,992,367 shares | $4,164,047 |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | — | 98,800 shares | $4,014,244 |
| BIOGEN INC | COM | 09062X103 | — | 18,437 shares | $3,983,498 |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | — | 65,000 shares | $3,923,400 |
| BELITE BIO INC | SPONSORED ADS | 07782B104 | — | 24,989 shares | $3,847,931 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 137,800 shares | $3,717,844 |
| PROKIDNEY CORP | SHS CL A | 74291D104 | — | 1,806,939 shares | $3,686,156 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 72,100 shares | $3,659,075 |
| ORUKA THERAPEUTICS INC | COM | 687604108 | — | 33,400 shares | $3,178,678 |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | — | 22,951 shares | $2,813,334 |
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | — | 5,000 shares | $2,709,150 |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | 10919W405 | — | 38,407 shares | $2,696,171 |
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | — | 29,200 shares | $1,867,340 |
| COMPASS THERAPEUTICS INC | COM | 20454B104 | — | 383,200 shares | $839,208 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 2,500 shares | $836,975 |
| KODIAK SCIENCES INC | COM | 50015M109 | — | 17,019 shares | $663,060 |
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | — | 42,080 shares | $612,264 |
| NUVALENT INC | COM | 670703107 | — | 4,900 shares | $605,150 |
| PEPGEN INC | COM | 713317105 | — | 205,324 shares | $369,583 |
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | — | 4,000 shares | $355,120 |